Tazarotene in combination with phototherapy

Area of Science:

• Dermatology
• Phototherapy
• Topical Therapeutics

Background:

• Psoriasis treatment requires safer and more effective options.
• Topical retinoids, like tazarotene, offer an alternative to oral retinoids, avoiding systemic side effects.
• Previous research indicates tazarotene's efficacy in mild-to-moderate psoriasis.

Purpose of the Study:

• To evaluate the efficacy and safety of a tazarotene-UVB combination therapy for psoriasis.
• To compare the tazarotene-UVB regimen against UVB monotherapy and vehicle gel plus UVB.

Main Methods:

• A 2-week pretreatment with topical tazarotene 0.1% gel daily.
• Subsequent 10-week treatment with tazarotene plus ultraviolet B (UVB) therapy three times weekly.
• Comparison group received UVB therapy alone or with vehicle gel.

Main Results:

• Tazarotene-UVB therapy demonstrated superior efficacy in reducing plaque elevation, scaling, and erythema compared to UVB alone or with vehicle gel.
• Treatment success (≥50% improvement) was achieved significantly faster with tazarotene-UVB (32 days) versus UVB monotherapy (67 days).
• The tazarotene-UVB regimen was well-tolerated, with no observed phototoxicity.

Conclusions:

• Combination therapy of topical tazarotene and UVB is a safe and effective treatment for mild-to-moderate psoriasis.
• This regimen offers a faster onset of action compared to UVB-based therapies alone.
• Tazarotene-UVB presents a viable therapeutic option with a favorable safety profile.